24 Dec 2020
Take a look at SENS a CGM system manufacturer ready to affect the diabetes treatment market (Think Descom only longer lasting Monitoring). Recent FDA approval of their product sold in the European market is primed to take off in the states.
Today it has gone from $.64 to $1.00+, biggest movement in the last 6 months for them due to this news. I got in at $.40 cents a while back.
Also, Medicare approved coverage and a few of the bigger private insurance companies have too. They are affiliated with Roche and now Ascensia in the Pharm world.
Good fortune on this one fellows.
SENS moved up to $1.46 today. There is an article on Zaks today about this.
A pending Call Option of $1.00 on 11 Feb 2021. For those of you versed in Options trading....please explain what this means in relation to the stock moving up. I do not trade with Options....so I can't explain it.
Good fortune to you all!